A review of several studies for the role for DNA methylation in PCa development[25], research has identified several methylation markers to be potentially associated with PCa risk, such as methylation at GSTP1, CDKN2A, DNMT3B, SCGB3A1, and HIF3A [25–29]. The gene discussed is CDKN2A; the disease is posterior cortical atrophy.